Welch & Forbes LLC Trims Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Welch & Forbes LLC trimmed its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 45.7% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 20,756 shares of the pharmacy operator’s stock after selling 17,482 shares during the period. Welch & Forbes LLC’s holdings in Walgreens Boots Alliance were worth $977,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of WBA. Red Door Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the 2nd quarter worth $35,000. Centerpoint Advisors LLC increased its holdings in Walgreens Boots Alliance by 203.8% during the 2nd quarter. Centerpoint Advisors LLC now owns 711 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 477 shares during the period. Strategic Blueprint LLC purchased a new position in Walgreens Boots Alliance during the 2nd quarter worth $38,000. Harel Insurance Investments & Financial Services Ltd. increased its holdings in Walgreens Boots Alliance by 425.7% during the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 736 shares of the pharmacy operator’s stock worth $126,000 after purchasing an additional 596 shares during the period. Finally, Newbridge Financial Services Group Inc. purchased a new position in Walgreens Boots Alliance during the 2nd quarter worth $40,000. Hedge funds and other institutional investors own 55.53% of the company’s stock.

In related news, Director Nancy M. Schlichting sold 2,725 shares of Walgreens Boots Alliance stock in a transaction dated Friday, November 19th. The stock was sold at an average price of $47.16, for a total value of $128,511.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 17.53% of the company’s stock.

NASDAQ WBA opened at $46.62 on Thursday. The stock has a 50-day simple moving average of $48.26 and a two-hundred day simple moving average of $49.67. The firm has a market capitalization of $40.35 billion, a P/E ratio of 15.91, a PEG ratio of 2.28 and a beta of 0.52. Walgreens Boots Alliance, Inc. has a fifty-two week low of $37.89 and a fifty-two week high of $57.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.35 and a current ratio of 0.72.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, October 14th. The pharmacy operator reported $1.17 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.02 by $0.15. The business had revenue of $34.26 billion during the quarter, compared to analyst estimates of $33.39 billion. Walgreens Boots Alliance had a return on equity of 20.76% and a net margin of 1.85%. The company’s revenue was up 12.8% on a year-over-year basis. During the same quarter last year, the business posted $1.02 EPS. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 4.96 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 10th. Shareholders of record on Monday, November 15th will be paid a dividend of $0.477 per share. The ex-dividend date is Friday, November 12th. This represents a $1.91 dividend on an annualized basis and a dividend yield of 4.09%. Walgreens Boots Alliance’s payout ratio is currently 65.19%.

Several research analysts have commented on the company. Truist raised their price objective on Walgreens Boots Alliance from $52.00 to $56.00 and gave the stock a “hold” rating in a report on Friday, October 15th. TheStreet downgraded Walgreens Boots Alliance from a “b-” rating to a “c” rating in a report on Friday, November 19th. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $50.00 price target on the stock. in a report on Wednesday, October 20th. Robert W. Baird reiterated a “buy” rating and issued a $68.00 price target on shares of Walgreens Boots Alliance in a report on Friday, September 3rd. Finally, Credit Suisse Group reiterated a “hold” rating and issued a $48.00 price target on shares of Walgreens Boots Alliance in a report on Friday, September 24th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $55.00.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA and Retail Pharmacy International. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

See Also: Bid-Ask Spread

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.